Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03263936
Title Epigenetic Reprogramming in Relapse/Refractory AML
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Therapeutic Advances in Childhood Leukemia Consortium
Indications
Therapies
Age Groups: adult | child
Covered Countries USA | CAN | AUS


No variant requirements are available.